GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 215 filers reported holding GENOMIC HEALTH INC in Q2 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,903,000 | -26.8% | 57,540 | -37.2% | 0.00% | -20.0% |
| Q2 2019 | $5,333,000 | -10.9% | 91,681 | +7.3% | 0.01% | -16.7% |
| Q1 2019 | $5,984,000 | +53.2% | 85,427 | +40.9% | 0.01% | +50.0% |
| Q4 2018 | $3,905,000 | -24.8% | 60,625 | -18.0% | 0.00% | -20.0% |
| Q3 2018 | $5,191,000 | +37.6% | 73,920 | -1.2% | 0.01% | +25.0% |
| Q2 2018 | $3,772,000 | +55.5% | 74,840 | -3.5% | 0.00% | +100.0% |
| Q1 2018 | $2,425,000 | -6.3% | 77,515 | +2.4% | 0.00% | 0.0% |
| Q4 2017 | $2,588,000 | +358.1% | 75,675 | +287.3% | 0.00% | +100.0% |
| Q3 2016 | $565,000 | -11.2% | 19,540 | -20.4% | 0.00% | 0.0% |
| Q2 2016 | $636,000 | +78.2% | 24,560 | +70.6% | 0.00% | – |
| Q1 2016 | $357,000 | -61.4% | 14,400 | -50.7% | 0.00% | -100.0% |
| Q2 2013 | $926,000 | – | 29,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |